1209 Reneo
BioCentury & Getty Images


Reneo to start pivotal trial in mitochondrial diseases, build orphan pipeline with Novo, Abingworth-led $95M series B

Company names Greg Flesher CEO

Reneo has designs on becoming a commercially-oriented, publicly traded company with multiple programs rather than a single-asset play.

Dec 9, 2020 | 8:46 PM GMT

With $95 million in

Read the full 539 word article

How to gain access

Continue reading with a
two-week free trial.